Raymond James Financial Services Advisors’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-13,892
| Closed | -$329K | – | 2926 |
|
|
2019
Q3 | $329K | Sell |
13,892
-15,859
| -53% | -$376K | ﹤0.01% | 2186 |
|
|
2019
Q2 | $895K | Buy |
29,751
+6,538
| +28% | +$197K | ﹤0.01% | 1567 |
|
|
2019
Q1 | $520K | Sell |
23,213
-16,072
| -41% | -$360K | ﹤0.01% | 1881 |
|
|
2018
Q4 | $715K | Buy |
39,285
+26,985
| +219% | +$491K | ﹤0.01% | 1449 |
|
|
2018
Q3 | $223K | Buy |
+12,300
| New | +$223K | ﹤0.01% | 2463 |
|